Pathology Industry in China Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 700 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in China - Forecast

  • November 2014
    48 pages
  • Cancer  

  • China  

    Asia  

    United States  

View report >

Pathology Description in China

  • Hengyi Mao, Wenzhe Ma, Hongyan Lu, Lu Wang, Hui Zheng, Yingying ...
  • October 2014
    11 pages
  • Pathology  

    Hiv  

  • China  

View report >

Pathology Description in China

  • And Susceptibility to Multiple Types of Cancer
  • September 2014
    11 pages
  • Cancer  

  • China  

View report >

Pathology Description in China

  • -transferase and Susceptibility to Endometrial Carcinoma
  • September 2014
    6 pages
  • Cancer  

  • China  

View report >

Pathology Description in China

  • Updated Version
  • September 2014
    9 pages
  • Cancer  

  • China  

View report >

Global Pathology Description

  • Blindness and Eye Diseases in Tibet: Findings from a Randomised,...
  • September 2014
    7 pages
  • Eye Disease  

    Blindness  

  • China  

    World  

View report >

Pathology Description in China

  • Estimates of Cancer Incidence in China for 2000 and Projections ...
  • September 2014
    9 pages
  • Cancer  

  • China  

    Asia  

View report >

Pathology Description in China

  • Aberrant Dna Methylation of in Combination with in Esophageal Sq...
  • September 2014
    9 pages
  • Pathology  

    Cancer  

  • China  

View report >

Pathology Description in China

  • Prevalence, Awareness, Treatment, and Control of Hypertension in...
  • September 2014
    9 pages
  • Hypertension  

  • China  

View report >

Pathology Description

  • Cancer in British Malaya and the Philippine Islands
  • September 2014
    11 pages
  • Pathology  

    Cancer  

  • Philippines  

    United Kingdom  

    China  

View report >

Search in Pathology Industry

About 300 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 300 - $ 4 995)

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

Non-hodgkin Lymphoma Therapeutics In Asia-pacific Marke ...

September 2014 $ 4 995

Epicast Report: Dyslipidemia - Epidemiology Forecast To ...

October 2014 $ 3 995

Epicast Report: Renal Cell Carcinoma - Epidemiology For ...

August 2014 $ 3 995

Herceptin (her2-positive Breast Cancer) - Forecast And ...

September 2014 $ 3 495

Perjeta (her2-positive Breast Cancer) - Forecast And Ma ...

September 2014 $ 3 495

Kadcyla (her2-positive Breast Cancer) - Forecast And Ma ...

September 2014 $ 3 495

Tykerb (her2-positive Breast Cancer) - Forecast And Mar ...

September 2014 $ 3 495

Neratinib (her2-positive Breast Cancer) - Forecast And ...

September 2014 $ 3 495

Mumps - Pipeline Review, H2 2014

November 2014 $ 2 000


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.